Methyl jasmonate inducible UGT79A18 is a novel glycosyltransferase involved in the bacoside biosynthetic pathway in Bacopa monnieri
Physiologia Plantarum · 2024
DOI: 10.1111/ppl.14260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiologia Plantarum, 2024. Verfasst von Sunil Kumar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Plant Biotechnology Division, Central Institute of Medicinal and Aromatic Plants, Lucknow, India. Hauptthemen laut MEDLINE: Bacopa, Triterpenes, Acetates, Cyclopentanes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, CSIR-CIMAP, Science and Engineering Research Board.
Abstract (Originalsprache)
Bacosides are dammarane‐type triterpenoidal saponins in Bacopa monnieri and have various pharmacological applications. All the bacosides are diversified from two isomers, i.e., jujubogenin and pseudojujubogenin. The biosynthetic pathway of bacoside is not well elucidated. In the present study, we characterized a UDP‐glycosyltransferase, UGT79A18 , involved in the glycosylation of pseudojujubogenin. UGT79A18 shows higher expression in response to 5 h of wounding, and 3 h of MeJA treatment. The recombinant UGT79A18 shows in vitro activity against a wide range of flavonoids and triterpenes and has a substrate preference for protopanaxadiol, a dammarane‐type triterpene. Secondary metabolite analysis of overexpression and knockdown lines of UGT79A18 in B. monnieri identify bacopasaponin D, bacopaside II, bacopaside N2 and pseudojujubogenin glucosyl rhamnoside as the major bacosides that were differentially accumulated. In the overexpression lines of UGT79A18, we found 1.7‐fold enhanced bacopaside II, 8‐fold enhanced bacopasaponin D, 3‐fold enhanced pseudojujubogenin glucosyl rhamnoside, and 1.6‐fold enhanced bacopaside N2 content in comparison with vector control plant, whereas in the knockdown lines of UGT79A18, we found 1.4‐fold reduction in bacopaside II content, 3‐fold reduction in the bacopasaponin D content, 2‐fold reduction in the pseudojujubogenin glucosyl rhamnoside content, and 1.5‐fold reduction in bacopaside N2 content in comparison with vector control. These results suggest that UGT79A18 is a significant UDP glycosyltransferase involved in glycosylating pseudojujubogenin and enhancing the pseudojujubogenin‐derived bacosides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Plant Biotechnology Division, Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Analytical Chemistry Laboratory, Regulatory Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, Uttar Pradesh, India.
- Botany Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, India.
ORCID-Profile: Rakesh Kumar Shukla
Förderung
- Council of Scientific and Industrial Research, India
- CSIR-CIMAP
- Science and Engineering Research Board
Zitieren
APA
Kumar, S., Singh, N., Lahane, V., Tripathi, V., Yadav, A. K., & Shukla, R. K. (2024). Methyl jasmonate inducible UGT79A18 is a novel glycosyltransferase involved in the bacoside biosynthetic pathway in Bacopa monnieri. Physiologia Plantarum. https://doi.org/10.1111/ppl.14260
Vancouver
Kumar S, Singh N, Lahane V, Tripathi V, Yadav AK, Shukla RK. Methyl jasmonate inducible UGT79A18 is a novel glycosyltransferase involved in the bacoside biosynthetic pathway in Bacopa monnieri. Physiologia Plantarum. 2024. doi:10.1111/ppl.14260
BibTeX
@article{Kumar2024,
author = {Kumar, Sunil and Singh, Neeti and Lahane, Vaibhavi and Tripathi, Vineeta and Yadav, Akhilesh Kumar and Shukla, Rakesh Kumar},
title = {Methyl jasmonate inducible UGT79A18 is a novel glycosyltransferase involved in the bacoside biosynthetic pathway in Bacopa monnieri},
journal = {Physiologia Plantarum},
year = {2024},
doi = {10.1111/ppl.14260}
}
EUVIMED